Search

Search Constraints

You searched for: Author/Creator Van Assche, G.

Search Results

1. Anti‐infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response. Issue 3 (11th December 2017)

5. Escalation to weekly dosing recaptures response in adalimumab‐treated patients with moderately to severely active ulcerative colitis. Issue 5 (15th July 2014)

9. Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis. Issue 2 (21st November 2017)